CeriBell (CBLL) Competitors $18.15 -0.58 (-3.10%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. NVST, TMDX, SLNO, ENOV, LIVN, NVCR, WRBY, LMAT, CNMD, and TNDMShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include Envista (NVST), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Enovis (ENOV), LivaNova (LIVN), NovoCure (NVCR), Warby Parker (WRBY), LeMaitre Vascular (LMAT), CONMED (CNMD), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. CeriBell vs. Envista TransMedics Group Soleno Therapeutics Enovis LivaNova NovoCure Warby Parker LeMaitre Vascular CONMED Tandem Diabetes Care Envista (NYSE:NVST) and CeriBell (NASDAQ:CBLL) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Does the media refer more to NVST or CBLL? In the previous week, Envista and Envista both had 7 articles in the media. Envista's average media sentiment score of 1.50 beat CeriBell's score of 0.41 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate NVST or CBLL? Envista presently has a consensus price target of $20.18, suggesting a potential upside of 33.17%. CeriBell has a consensus price target of $32.50, suggesting a potential upside of 79.06%. Given CeriBell's stronger consensus rating and higher possible upside, analysts plainly believe CeriBell is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 2 Sell rating(s) 10 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer NVST or CBLL? Envista received 24 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 33.33% of users gave Envista an outperform vote. CompanyUnderperformOutperformEnvistaOutperform Votes3433.33% Underperform Votes6866.67% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Which has better earnings & valuation, NVST or CBLL? CeriBell has lower revenue, but higher earnings than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvista$2.51B1.04-$1.12B-$6.49-2.33CeriBell$65.44M9.95N/AN/AN/A Is NVST or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets Envista-44.56% 3.86% 2.21% CeriBell N/A N/A N/A SummaryCeriBell beats Envista on 6 of the 11 factors compared between the two stocks. Remove Ads Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$651.08M$3.15B$5.40B$7.28BDividend YieldN/A1.64%4.87%4.05%P/E RatioN/A14.1622.8817.61Price / Sales9.9542.11357.3086.64Price / CashN/A44.0938.1634.64Price / BookN/A3.166.323.86Net IncomeN/A$94.03M$3.21B$247.18M7 Day Performance-6.73%-4.19%-6.89%-6.27%1 Month Performance-23.61%-12.19%-1.87%-8.87%1 Year PerformanceN/A-24.10%4.62%-6.18% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBellN/A$18.15-3.1%$32.50+79.1%N/A$651.08M$65.44M0.00N/ALockup ExpirationNews CoverageGap DownNVSTEnvista4.704 of 5 stars$17.51+5.1%$20.18+15.3%-20.5%$3.01B$2.51B-2.7012,700News CoveragePositive NewsTMDXTransMedics Group2.4963 of 5 stars$71.47+3.5%$122.70+71.7%-5.8%$2.41B$441.54M76.03210Gap DownSLNOSoleno Therapeutics4.5567 of 5 stars$50.14+2.1%$71.20+42.0%+72.8%$2.30BN/A-15.1030Insider TradeAnalyst RevisionENOVEnovis3.0562 of 5 stars$40.01+2.4%$58.50+46.2%-43.1%$2.28B$2.11B-18.276,550Analyst ForecastNews CoverageGap DownLIVNLivaNova3.969 of 5 stars$40.37+2.3%$61.17+51.5%-30.5%$2.19B$1.25B96.122,900Positive NewsGap DownNVCRNovoCure3.2093 of 5 stars$19.78+2.3%$35.80+81.0%+17.8%$2.17B$605.22M-14.131,320News CoverageGap DownWRBYWarby Parker3.4974 of 5 stars$20.19+6.8%$23.43+16.1%+21.1%$2.09B$771.32M-74.763,491Positive NewsGap DownLMATLeMaitre Vascular3.0496 of 5 stars$86.07+3.1%$95.25+10.7%+28.3%$1.94B$219.86M47.03490Gap DownCNMDCONMED4.6456 of 5 stars$60.86+2.0%$77.20+26.8%-25.8%$1.88B$1.31B14.354,100Short Interest ↑News CoveragePositive NewsGap DownTNDMTandem Diabetes Care4.4696 of 5 stars$20.62+1.6%$45.38+120.1%-48.5%$1.37B$940.20M-10.682,400News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Envista Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Enovis Alternatives LivaNova Alternatives NovoCure Alternatives Warby Parker Alternatives LeMaitre Vascular Alternatives CONMED Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts